Target intelligence / Profile preview

Microtubule-associated protein 7 (MAP7) mRNA 3'-untranslated region (3'-UTR) (MAP7 mRNA 3'-UTR)

Target
MAP7 mRNA 3'-UTR
Molecular classification
RNA, Messenger RNA (mRNA), Regulatory RNA element
01

Overview

The Microtubule-associated protein 7 (MAP7) mRNA 3'-untranslated region (3'-UTR) is a critical regulatory segment of the messenger RNA encoding the MAP7 protein, also known as ensconsin. This region contains multiple binding sites for microRNAs (miRNAs) and RNA-binding proteins that modulate the stability and translation efficiency of the MAP7 transcript (Source: UniProt O60318). MAP7 itself is a key regulator of the microtubule cytoskeleton, functioning to stabilize microtubules and recruit kinesin-1 motors for intracellular transport (Source: PubMed: 29610382). In several malignancies, including colorectal and breast cancers, the MAP7 3'-UTR is a focal point for dysregulation; specifically, the loss of inhibitory miRNAs that normally bind this region leads to MAP7 overexpression, which promotes tumor cell invasion and metastasis (Source: PubMed: 30612335). Therapeutic approaches targeting the MAP7 mRNA 3'-UTR involve the use of miRNA mimics or antisense oligonucleotides (ASOs) designed to bind the 3'-UTR and reduce MAP7 protein levels, thereby inhibiting oncogenic progression (Source: PubMed: 31256145). As an RNA-based target, it offers a specific pathway for precision medicine in cancers where MAP7 is a driver of disease.

Other names
Ensconsin mRNA 3'-UTRE-MAP-115 mRNA 3'-UTRMAP-7 mRNA 3'-UTRMTAP7 mRNA 3'-UTR
02

Mechanism of action

MicroRNA-mediated silencing or antisense oligonucleotide-induced degradation of the MAP7 mRNA transcript via sequence-specific binding to the 3'-untranslated region.

03

Biological functions

Regulation of mRNA stabilityTranslational regulationMicrotubule organizationKinesin-1 recruitmentCell migration
04

Disease associations

Colorectal cancerBreast cancerGastric cancerLung adenocarcinomaHepatocellular carcinoma
05

Safety considerations

Off-target silencing of other genes with seed-sequence complementarityPotential for immune activation by exogenous RNA moleculesDisruption of normal MAP7-mediated microtubule stabilization in non-cancerous tissuesDelivery-related toxicity of RNA-based therapeutics
06

Interacting drugs

miR-211-5p mimic

5 more in the full profile.

07

Biomarkers

MAP7 mRNA expression levelsMAP7 protein levelsmiR-211-5p expression levelsmiR-374a-5p expression levels

Beyond the preview

Go deeper on Microtubule-associated protein 7 (MAP7) mRNA 3'-untranslated region (3'-UTR) (MAP7 mRNA 3'-UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microtubule-associated protein 7 (MAP7) mRNA 3'-untranslated region (3'-UTR) (MAP7 mRNA 3'-UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call